Date: Tuesday 26th April
Time: 16:00-17:00 BST
Speakers: Franz König (Medical University of Vienna) and Juliane Manitz (EMD Serono)
Our next journal club features two papers on the topic of “Treatment Switching in Clinical Trials”. Please join us to hear Franz König (Medical University of Vienna) and Juliane Manitz (EMD Serono) present their recent work. The webinar will be chaired by Chrissie Fletcher (GSK).
To view the flyer for this event, please click here.
This event is sponsored by Wiley.
This event is open to both Members and Non-Members of PSI.
REGISTER HERE: https://us06web.zoom.us/webinar/register/WN_ukE6-LZVQCiwZp3UfMwQhw
Franz König (Medical University of Vienna) - Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology.
Robin Ristl, Nicolás M Ballarini, Heiko Götte, Armin Schüler, Martin Posch & Franz König
Pharmaceutical Statistics.2021;20:129–145.
Juliane Manitz (EMD Serono) - Estimands for overall survival in clinical trials with treatment switching in oncology.
Juliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, Marie-Laure Casadebaig, Evgeny Degtyarev, Jyotirmoy Dey et al.
Pharmaceutical Statistics. 2022;21(1):150-162.
For each of these published papers there will be a 20 minute presentation by the author, followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
